Navigation Links
AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve
Date:9/17/2009

WILMINGTON, Del., Sept. 17 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.

AstraZeneca US President Rich Fante accepted the award on behalf of AstraZeneca and was joined by AstraZeneca Vice President of Human Resources, Marta Perez, and members of the company's Military Support Employee Network Group.

"I am proud of how AstraZeneca leaders and employees are supporting not only their colleagues who serve in the National Guard and Reserve, but also their families and community members," Fante, a former Army Reservist, said.

AstraZeneca was nominated for the award by an employee from New Jersey, a current U.S. Army Reserve lieutenant colonel who has served in Afghanistan and Iraq. The company employs more than 100 men and women serving in the National Guard or Reserve, and was one of 15 employers chosen for this award from among more than 3,200 total nominations.

AstraZeneca provides flexible policies and benefits designed to ease burdens on employees serving in the National Guard or Reserve, including:

  • Providing the difference between a service member's regular pay and military pay for military service up to 24 months, after which time each employee's situation is reviewed on a case-by-case basis
  • Offering continuation of health and dental insurance for periods of military service greater than 12 months. Additionally, company-provided life insurance continues for one year after the start of the military leave and can be converted to a private plan after one year
  • Fostering a Military Support Employee Network Group, which is made up of 200 members including National Guard members and Reservists, employees who are veterans, employees whose family members are either veterans or who are currently in the service, plus employees who want to show their support of troops
  • Maintaining contact with the families of Guard and Reserve employees during periods of military service

The Freedom Award was instituted in 1996 under the auspices of the National Committee for Employer Support of the Guard and Reserve (ESGR) to recognize exceptional support from the employer community.

AstraZeneca has received numerous ESGR state awards for its support for National Guard and Reserve employees, including several Patriot Awards, the Above and Beyond Award and the Pro Patria Award.

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: www.astrazeneca-us.com.


'/>"/>
SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: AstraZeneca Traveling Exhibit Helps Americans Understand and Manage Bipolar Depression
2. AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries
3. AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
4. AstraZeneca Expands Prescription Savings Program
5. AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured
6. AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease
7. Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
8. Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
9. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
10. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
11. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched ... The drinks have been produced in collaboration with Zlatan Ibrahimovic and have been ... , After a successful launch in Sweden last year, the next generation sports ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a ... has set out for each of his children. “The Angel” is the creation of ... Music in New York City, and impassioned writer. , When asked of her new ...
(Date:1/20/2017)... ... , ... “I Forgive You”: a fine examination of how God handles sin, including how ... published author, Stephen Miller, who, for over ten long years has been waiting to release ... Trinidad and Tobago, he has been serving the Lord for over twenty years, and he ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Christmas in Suffolk”: ... of published author, Sara Seymour, who lives in Lafayette, Indiana where she works in ... on iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new ...
(Date:1/20/2017)... ... 2017 , ... “Knowledge is God’s Lighthouse”: a moving and colorful collection ... is the creation of published author, Gene Gaapf, a retired truck driver, and a ... have been writing since high school and have many different titles,” Gaapf mentions about ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... ... Forecast 2016-2026: Opportunities for Leading Companies – our new ... new report discusses issues and events affecting the Alzheimer,s ... qualitative analyses to answer these key questions: - How ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ... to treat mitochondrial dysfunction, today announced new additions to ... M.D., as Chief Medical Officer, and Daniel Geffken ... announced that Jim Carr , Pharm.D. has been ... "We are pleased to welcome Doug and Daniel to ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
Breaking Medicine Technology: